Trinity Capital Provides $30MM in Growth Capital to Elucent Medical
Trinity Capital, an alternative asset manager, committed $30 million in growth capital to Elucent Medical, a medical technology company. “Elucent is disrupting the field of surgical guidance with its cutting-edge technology,” Lauren Cosentino, managing director, life sciences at Trinity Capital,...
Read moreDetails









